Comparative analysis of the reports of suspected adverse drug reactions (ADRs) associated with the use of oral anticoagulants
Latest Information Update: 19 Aug 2022
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Stroke; Venous thromboembolism
- Focus Adverse reactions
Most Recent Events
- 19 Aug 2022 New trial record
- 28 Jun 2022 Results presented at the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2022